New Drug Targets Tau in Alzheimer's | Odessa News

Odessa News Today | 2 Min News | The Daily News Now! · Jul 14, 2026 · 1m

A breakthrough in Alzheimer’s research could be on the horizon with diranersen, a new experimental drug that directly targets tau protein—instead of amyloid—by reducing its production at the genetic level. Early results show promise in slowing early-stage Alzheimer’s, offering a fresh approach after past tau-targeting efforts failed. While still in early stages, the drug has sparked excitement in the scientific community and may pave the way for new therapies, including tau vaccines and repurposed heart meds. Researchers are also exploring smarter drug delivery and combination treatments to…